Medical Hypotheses
Volume 56, Issue 1 , Pages 58-64 , January 2001

Polyploidization: a Janus-faced mechanism

  • R.G. Hanselmann

      Affiliations

    • Department of Experimental Physics, Saarbrücken, Germany
    • ,
  • M. Oberringer

      Affiliations

    • Department of Surgery, University of Saarland, Homburg, Germany

Received 31 January 2000 ,Accepted 28 February 2000.

References 

    REFERENCES
  1. Therman E, Millard S. Chromosomal Development of Cancer. In:  Therman E,  Millard S editor. Human Chromosomes. Stucture, Behavior, and Effects (Third Edition). New York, Berlin, Heidelberg: Springer Verlag,; 1993;p. 321–330
  2. Sarto GE, Stubblefield PA, Therman E. Endomitosis in human trophoblast. Hum Genet. 1982;62:228–232
  3. Mohr W, Kesenheimer M, Beneke G. Altersabhängige Polyploidisierung der Zellkerne menschlicher Samenblasenepithelien. Beitr Path. 1974;151:331–343
  4. Vliegen HW, Eulderink F, Bruschke AV, van der Laarse A, Cornelisse CJ. Polyploidy of myocyte nuclei in pressure overloaded human hearts: a flow cytometric study in left and right ventricular myocardium. Am J Cardiovasc Pathol. 1995;5:27–31
  5. Altmann HW, Loeschke K, Schenk K. Über das Karyogramm der menschlichen Leber unter normalen und pathologischen Bedingungen. Vierch Arch Path Anal. 1966;341:85–101
  6. Gilbert P, Pfitzer P. Facultative polyploidy in endocrine tissues. Virchows Arch B Cell Pathol. 1977;25:233–242
  7. Ermis A, Oberringer M, Wirbel R, Koschnick M, Mutschler W, Hanselmann RG. Tetraploidization is a physiological enhancer of wound healing. Eur Surg Res. 1998;30:385–392
  8. Oberringer M, Lothschütz D, Jennewein M, Koschnick M, Mutschler W, Hanselmann R. Centrosome-multiplication accompanies a transient clustering of polyploid cells during tissue repair. MCBRC. 1999;2:190–196
  9. Rofstad EK, Johnson NM, Lyng H. Hypoxia-induced tetraploidisation of a diploid human melanoma cell line in vitro. Br J Cancer. 1996;74:136–139
  10. Bellamy COC, Clarke AR, Wyllie AH, Harrison DJ. p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA-damage. FASEB Journal. 1997;11:591–599
  11. Gahan PB. Increased levels of euploidy as a strategy against rapid ageing in diploid mammalian systems: a hypothesis. Exp Geront. 1977;12:133–136
  12. Israel L. Tumour Progression: Random mutations or an integrated survival response to cellular stress conserved from unicellular organisms?. J Theor Biol. 1996;178:375–380
  13. Mao L. Leukoplakia: molecular understanding of pre-malignant lesions and implications for clinical management. Mol Med Today. 1997;Oct:442–448
  14. Chryssochoos JT, Weber CJ, Cohen C. DNA index and ploidy distinguish normal human parathyroids from parathyroid adenomas and primary hyperplastic parathyroids. Surgery. 1995;118:1041–1050
  15. Rabinovitch PS, Reid BJ, Haggitt RC, Norwood TH, Rubin CE. Progression to Cancer in Barrett’s esophagus is associated with genomic instability. Lab Invest. 1988;60:65–71
  16. Asamura, H. Nakajima, T. Mukai, K. Noguchi, M. Shimosato, Y. 1989, DNA cytofluorometric and nuclear morphometric analyses of adenocarcinoma. Cancer, 1989, 64, 1657, 1664
  17. Nasiell, M. Kato, H. Auer, G. Zetterberg, A. Roger, V. Karlen, L. 1978, Cytomorphological grading and Feulgen DNA-analysis of metaplastic and neoplastic bronchial cells. Cancer, 1978, 41, 1511, 1521
  18. Shimosato, Y. Noguchi, M. Yoshihiro, M. 1993, Adenocarcinoma of the lung: its development and malignant progression. Lung Cancer, 1973, 9, 99, 108
  19. Porschen R, Robin U, Schumacher A, Schauseil S, Borchard F, Hengels KJ, et al. DNA aneuploidy in Crohn’s disease and ulcerative colitis: results of a comparative flow cytometric study. Gut. 1992;33:663–667
  20. Melville DM, Jass JR, Shepherd NA. Dysplasia and desoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Gastroenterology. 1988;95:668–675
  21. Ramel S, Sanchez CA, Schimke MK, Neshat K, Cross SM, Raskind WH, et al. Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas. Pancreas. 1995;11:213–222
  22. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, et al. A p53- dependent mouse spindle checkpoint. Science. 1995;267:1353–1356
  23. Andreassen PR, Martineau SN, Margolis RL. Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat Res. 1996;372:181–194
  24. Faschingbauer M, Jürgens C, Schmidt HGK, Wolter D. Ergebnisse der Behandlung von Narben-und Fistelcarcinomen. Der Chirurg. 1995;66:1141–1145
  25. Levan A, Hauschka TS. Endomitotic reduplication mechanism in ascites tumors of the mouse. J Natl Cancer Inst. 1953;14:1–46
  26. Therman E, Kuhn EM. Mitotic modifications and aberrations in cancer. Crit Rev Oncogenesis. 1989;1:293–305
  27. Gualberto A, Aldape K, Kozakiewicz K, Tlsty TD. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc Natl Acad Sci USA. 1998;95:5166–5171
  28. Agapova LS, Ilyinskaya GV, Turovets NA, Ivanov AV, Chumakov PM, Kopnin BP. Chromosome changes caused by alterations of p53 expression. Mut Res. 1996;354:129–138
  29. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty T. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 1992;70:923–935
  30. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene. 1993;8:2457–2467
  31. Levine DS, Sanchez CA, Rabinovitch PS, Reid BJ. Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci USA. 1991;88:6427–6431
  32. Ullrich SJ, Anderson CW, Mercer WE, Appella E. The p53 tumor suppressor protein, a modulator of cell proliferation. J Biol Chem. 1992;267:15259–15262
  33. Hartwell LH, Kastan MB. Cell cycle control and Cancer. Science. 1994;266:1821–1828
  34. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebemann DA. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage induced apoptosis. Oncogene. 1995;10:2263–2270
  35. Schwartz D, Rotter V. p53-dependant cell cycle control: response to genotoxic stress. Sem Canc Biol. 1998;8:325–336
  36. Fukasawa K, Choi T, Kuriyama SR, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science. 1996;271:1744–1747
  37. Vidair CA, Doxsey SJ, Dewey WC. Heat shock alters centrosome organization leading to mitotic disfunction and cell death. Journal of Cellular Physiology. 1993;154:442–455
  38. Schmid W. Multipolar spindles after endoreduplication. Exp Cell Res. 1965;42:201–204
  39. Gottlieb TM, Oren M. p53 and apoptosis. Semin Cancer Biol. 1999;8:359–368
  40. Hainault P, Milner J. Interaction of heat shock protein 70 with p53 translated in vitro: Evidence for interaction with dimeric p53 and for a role in regulation of p53 conformation. EMBO J. 1992;11:3513–3520
  41. Brown CR, Doxsey SJ, White E, Welch WJ. Both viral (adenovirus EIB) and cellular (hsp 70, p53) components interact with centrosomes. J Cell Physiol. 1994;160:47–60

PII: S0306-9877(00)91111-3

doi: 10.1054/mehy.2000.1111

Medical Hypotheses
Volume 56, Issue 1 , Pages 58-64 , January 2001

Article Tools